PERI, FRANCESCO
 Distribuzione geografica
Continente #
NA - Nord America 38.645
EU - Europa 21.660
AS - Asia 11.064
SA - Sud America 1.570
Continente sconosciuto - Info sul continente non disponibili 1.444
AF - Africa 275
OC - Oceania 43
Totale 74.701
Nazione #
US - Stati Uniti d'America 37.577
DE - Germania 5.626
SE - Svezia 4.602
IT - Italia 3.565
SG - Singapore 3.375
DK - Danimarca 2.820
CN - Cina 2.541
VN - Vietnam 1.818
HK - Hong Kong 1.306
BR - Brasile 1.209
RU - Federazione Russa 1.205
CA - Canada 868
IE - Irlanda 630
GB - Regno Unito 564
FR - Francia 548
UA - Ucraina 535
PL - Polonia 414
IN - India 409
BD - Bangladesh 318
FI - Finlandia 244
AT - Austria 237
NL - Olanda 219
KR - Corea 203
ID - Indonesia 159
TR - Turchia 143
JP - Giappone 130
IQ - Iraq 123
ES - Italia 121
AR - Argentina 108
BE - Belgio 98
MX - Messico 98
PK - Pakistan 96
ZA - Sudafrica 89
SA - Arabia Saudita 60
EC - Ecuador 58
CO - Colombia 55
PH - Filippine 51
VE - Venezuela 43
UZ - Uzbekistan 42
CH - Svizzera 41
MY - Malesia 38
RO - Romania 38
CL - Cile 37
AU - Australia 31
MA - Marocco 31
LT - Lituania 29
EG - Egitto 28
IR - Iran 27
TW - Taiwan 26
KE - Kenya 25
AE - Emirati Arabi Uniti 23
PY - Paraguay 23
ET - Etiopia 22
JO - Giordania 22
NP - Nepal 22
TN - Tunisia 21
IL - Israele 19
DZ - Algeria 18
AZ - Azerbaigian 17
CZ - Repubblica Ceca 17
PT - Portogallo 17
CR - Costa Rica 16
GR - Grecia 15
JM - Giamaica 15
PE - Perù 13
TH - Thailandia 13
EU - Europa 12
LB - Libano 12
NZ - Nuova Zelanda 11
BO - Bolivia 10
DO - Repubblica Dominicana 10
UY - Uruguay 10
AL - Albania 9
NI - Nicaragua 9
HN - Honduras 8
HU - Ungheria 8
KZ - Kazakistan 8
LV - Lettonia 8
NO - Norvegia 8
OM - Oman 8
PS - Palestinian Territory 8
RS - Serbia 8
BB - Barbados 7
BG - Bulgaria 7
KG - Kirghizistan 7
PA - Panama 7
TT - Trinidad e Tobago 7
MU - Mauritius 6
SY - Repubblica araba siriana 6
MD - Moldavia 5
NG - Nigeria 5
A2 - ???statistics.table.value.countryCode.A2??? 4
AM - Armenia 4
AO - Angola 4
BY - Bielorussia 4
EE - Estonia 4
GE - Georgia 4
GY - Guiana 4
SC - Seychelles 4
SN - Senegal 4
Totale 73.191
Città #
Ann Arbor 19.992
Frankfurt am Main 5.175
Stockholm 3.752
Ashburn 1.933
Singapore 1.898
Hong Kong 1.252
San Jose 1.216
Woodbridge 1.151
Milan 1.132
Wilmington 1.097
Chandler 942
Fairfield 884
Houston 625
Dublin 603
Toronto 546
Jacksonville 509
Ho Chi Minh City 496
Council Bluffs 471
Santa Clara 406
Seattle 379
Hanoi 367
Rome 362
Beijing 356
Los Angeles 330
Kraków 329
Dearborn 312
New York 307
Chicago 294
Hefei 270
Cambridge 269
Princeton 232
Dong Ket 220
Vienna 210
Boardman 192
Nanjing 191
Dallas 187
Seoul 183
The Dalles 180
Shanghai 154
São Paulo 139
Altamura 131
Guangzhou 131
Buffalo 130
Lauterbourg 121
Jakarta 120
Columbus 113
Lawrence 107
Helsinki 103
Phoenix 96
Tokyo 94
Brussels 85
San Diego 85
Lachine 80
Moscow 80
Orem 78
Florence 71
Munich 61
London 60
Chennai 57
Da Nang 56
Montreal 56
Atlanta 55
Warsaw 55
Washington 55
Amsterdam 54
Brooklyn 54
Turin 53
Ottawa 50
Hangzhou 48
Johannesburg 48
Fremont 47
Hyderabad 46
Jinan 46
Baghdad 45
Denver 45
Haiphong 45
Tianjin 45
Falls Church 42
Bologna 41
Nuremberg 40
Montréal 39
Shenyang 39
Tashkent 39
Hebei 38
Nanchang 38
Rio de Janeiro 38
Boston 37
Andover 36
Brescia 36
Changsha 36
Dhaka 36
Naples 36
Paris 36
Philadelphia 36
Salt Lake City 35
Brasília 34
Newark 34
San Francisco 32
Piscataway 31
Biên Hòa 29
Totale 53.087
Nome #
Representative secondary PET micro and nanoplastics via ethylene glycol fragmentation (EGF): Physicochemical and immuno-toxicological properties 2.039
Validating Natural Compounds as Toll-Like Receptor 4 (TLR4) Antagonists: Experimental Challenges and Therapeutic Perspectives 1.968
Novel carboxylate-based glycolipids: TLR4 antagonism, MD-2 binding and self-assembly properties 863
Synthetic and natural small molecule TLR4 antagonists inhibit motoneuron death in cultures from ALS mouse model 838
Structure–Activity Relationship in Monosaccharide-Based Toll-Like Receptor 4 (TLR4) Antagonists 831
Toll-like receptor 4 modulation influences human neural stem cell proliferation and differentiation 819
Selective cytotoxicity of a bicyclic Ras inhibitor in cancer cells expressing K-RasG13D 782
Amphiphilic Guanidinocalixarenes Inhibit Lipopolysaccharide (LPS)-and Lectin-Stimulated Toll-like Receptor 4 (TLR4) Signaling 773
Structural characterization of aerogels derived from enzymatically oxidized galactomannans of fenugreek, sesbania and guar gums 746
TLR4 antagonist FP7 inhibits LPS-induced cytokine production and glycolytic reprogramming in dendritic cells, and protects mice from lethal influenza infection 727
A new advanced cellular model of functional cholinergic-like neurons developed by reprogramming the human SH-SY5Y neuroblastoma cell line 719
The Multi-Level Mechanism of Action of a Pan-Ras Inhibitor Explains its Antiproliferative Activity on Cetuximab-Resistant Cancer Cells 715
Recent advances on Toll-like receptor 4 modulation: new therapeutic perspectives 711
Dye-sensitized photocatalytic hydrogen production: Distinct activity in a glucose derivative of a phenothiazine dye 707
First experimental identification of Ras-inhibitor binding interface using a water-soluble Ras ligand 696
Functional characterization of E. coli LptC: Interaction with LPS and a synthetic ligand 695
The Role of TLR4 in Neural Stem Cells–Mediated Neurogenesis and Neuroinflammation 693
Co-administration of Antimicrobial Peptides Enhances Toll-like Receptor 4 Antagonist Activity of a Synthetic Glycolipid 690
The role of carbohydrates in the lipopolysaccharide (LPS)/toll-like receptor 4 (TLR4) Signalling 689
Structure-Activity Studies on Arylamides and Arysulfonamides Ras Inhibitors 685
Synthesis of the New Cyanine-Labeled Bacterial Lipooligosaccharides for Intracellular Imaging and in Vitro Microscopy Studies 683
Glucose-derived Ras pathway inhibitors: evidence of Ras-ligand binding and Ras-GEF (Cdc25) interaction inhibition 660
Modulation of CD14 and TLR4·MD-2 activities by a synthetic lipid A mimetic 654
Binding properties and biological characterization of new sugar-derived Ras ligands 648
Dye-Sensitized Photocatalytic Hydrogen Generation: Efficiency Enhancement by Organic Photosensitizer-Coadsorbent Intermolecular Interaction 648
TLR4 signaling pathway modulators as potential therapeutics in inflammation and sepsis 639
Exploring the LPS/TLR4 signal pathway with small molecules 638
Glycolipids and benzylammonium lipids as novel antisepsis agents: Synthesis and biological characterization 637
Glycolipid-based TLR4 Modulators and Fluorescent Probes: Rational Design, Synthesis, and Biological Properties 636
Structure and inflammatory activity of the LPS isolated from Acetobacter pasteurianus CIP103108 628
Uniform lipopolysaccharide (LPS)-loaded magnetic nanoparticles for the investigation of LPS-TLR4 signaling 617
Trehalose- and glucose-derived glycoamphiphiles: Small-molecule and nanoparticle toll-like receptor 4 (TLR4) modulators 616
Metabolism of Phosphatidylinositol 4-Kinase IIIα-Dependent PI4P Is Subverted by HCV and Is Targeted by a 4-Anilino Quinazoline with Antiviral Activity 614
Glial TLR4 receptor as new target to treat neuropathic pain: efficacy of a new receptor antagonist in a model of peripheral nerve injury in mice 611
Structure-Activity Studies on Arylamides and Arysulfonamides Ras Inhibitors 611
Toll-like Receptor 4 (TLR4) Modulation by Synthetic and Natural Compounds: An Update 607
Effect of chemical modulation of toll-like receptor 4 in an animal model of ulcerative colitis 602
A Synthetic Lipid A Mimetic Modulates Human TLR4 Activity 601
Therapeutic targeting of innate immunity with Toll-like receptor 4 (TLR4) antagonists 596
Hemin and a metabolic derivative coprohemin modulate the TLR4 pathway differently through different molecular targets 592
The cationic amphiphile 3,4-bis (tetradecyloxy) benzylamine inhibits LPS signaling by competing with endotoxin for CD14 binding 584
Synthesis and biological evaluation of novel lipid A antagonists 583
How do viruses interfere with Toll-like receptor 4? 573
Synthetic molecules and functionalized nanoparticles targeting the LPS-TLR4 signaling: a new generation of immunotherapeutics 570
A new isoluminol reagent for chemiluminescence labeling of proteins 570
Inhibition of lipid A stimulated activation of human dendritic cells and macrophages by amino and hydroxylamino monosaccharides 549
Modulation of LPS signaling through TLR4 agonists and antagonists 549
Evidence of a specific interaction between new synthetic antisepsis agents and CD14 547
Sugar-derived Ras inhibitors: Group epitope mapping by NMR spectroscopy and biological evaluation 546
Design and characterisation of a new class of inhibitors of Ras activation 545
The synthetic glycolipid-based TLR4 antagonist FP7 negatively regulates in vitro and in vivo haematopoietic and non-haematopoietic vascular TLR4 signalling 545
Multivalent glycoconjugates as anti-pathogenic agents 534
Design, Synthesis and Biological Evaluation of Levoglucosenone-derived Ras Activation Inhibitors 530
Optimizing operating conditions and electrochemical characterization of glucose-gluconate alkaline fuel cells 529
Compound for the covalent attachment of the chemiluminescent probe N-(4-Aminobutyl)-N-ethylisoluminol (ABEI) to target molecules and uses thereof 529
Clustered carbohydrates in synthetic vaccines 524
Rigid polycycles and peptidomimetics from carbohydrate synthons 523
Carbohydrate-based bioactive compounds for medicinal chemistry applications 521
Design, synthesis and biological evaluation of sugar-derived Ras inhibitors 512
NEW SYNTHETIC AGONISTS OF TLR4 RECEPTOR 511
Editorial 511
Arabinose-derived Bicyclic Amino Acids: Synthesis, Conformational Analysis and Construction of an avb3-selective RGD Peptide 508
Glycoconjugates in cancer therapy 505
Novel α-conotoxin from Conus spurius and the α-conotoxin EI share high-affinity potentiation and low-affinity inhibition of nicotinic acetylcoline receptors 500
Chemistry of lipid a: At the heart of innate immunity 498
Carbohydrate Scaffolds for the Production of Bioactive Compounds 497
Chemoselective neoglycosylation 496
A novel small molecule TLR4 antagonist (IAXO-102) negatively regulates non-hematopoietic toll like receptor 4 signalling and inhibits aortic aneurysms development 490
Clicked and long spaced galactosyl- and lactosylcalix[4]arenes: New multivalent galectin-3 ligands 489
Green and Roasted Coffee Extracts Inhibit Interferon-β Release in LPS-Stimulated Human Macrophages 486
Synthesis and biological evaluation of an anticancer vaccine containing the C-glycoside analogue of the Tn epitope 484
Looking forward: A glance into the future of organic chemistry 481
Sugar-Based Inhibitors of Ras Activation: Biological Activity and Identification of Ras–Inhibitor Binding Interface 478
Studies on the mechanism of action of a new class of inhibitors of Ras activation 476
Sugar-derived amino acids: powerful secondary structure inducing elements in the design of novel peptidomimetics 475
Extending chemoselective ligation to sugar chemistry:convergent assembly of bioactive neoglycoconjugates 474
Glycoconjugate and oligosaccharide mimetics by chemoselective ligation 473
Polycyclic Scaffolds from Fructose 473
Chemoselective Ligation in Glycochemistry 473
Synthesis of imino sugar scaffolds for the generation of glycosidase inhibitor libraries 472
Synthesis of bicyclic sugar azido acids and their incorporation in cyclic peptides 471
Solution and solid-phase chemoselective synthesis of (1-6)-amino(methoxy) di- and trisaccharide analogues 471
Molecular simplification of lipid A structure: TLR4-modulating cationic and anionic amphiphiles 470
Synthesis of imino-C-disaccharides related to sucrose 464
Discrimination Properties of Tetraamidic Branched Selectors 463
Assembly of binding loops on aromatic templates as V CAM-1 mimetics 460
Developing New Anti-Tuberculosis Vaccines: Focus on Adjuvants 460
Carbohydrate-based Scaffolds for the generation of sortiments of bioactive compounds 459
Lipid A antagonists with anti-septic shock, anti-inflammatory, anti-ischemia and analgesic activity 457
Conversion of lactose into mimics of N-acetyllactosamine 455
A new procedure for the synthesis of C-glycosides of nojirimycin 450
D-glucose as a regioselectively addressable scaffold for combinatorial chemistry on solid phase 449
The EuroSciCon's 2015 Innate Immunity Summit 446
Chemoselective glycosylation techniques for the synthesis of bioactive neoglycoconjugates, glyconanoparticles and glycoarrays 445
Stepwise synthesis and structural characterization of calix[4]- and calix[5]arenes bearing a functionalized arm on the methylene bridge 444
Regioselection and orthogonality of the 1-phenyl-3-butenyl (PBU) protecting group in glucopyranosides 443
Tin-mediated regioselective acylation of unprotected sugars on solid phase 443
Stereoselective synthesis of α-C-glycosides of N-acetylgalactosamine 442
The bone morphogenic protein antagonist Drm/gremlin is a novel pro- angiogenic factor 438
Istaroxime Metabolite PST3093 Selectively Stimulates SERCA2a and Reverses Disease-Induced Changes in Cardiac Function 436
Totale 59.603
Categoria #
all - tutte 173.451
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 173.451


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20227.888 0 0 0 1.112 887 869 785 847 676 868 787 1.057
2022/20238.296 1.376 1.724 1.100 997 928 1.111 161 295 250 175 104 75
2023/20242.842 84 188 345 160 351 433 448 141 184 86 110 312
2024/20256.194 324 548 455 326 461 300 334 353 588 926 547 1.032
2025/202619.520 1.885 981 1.133 1.638 1.611 788 2.028 676 1.588 5.207 986 999
2026/20273.001 443 669 1.540 349 0 0 0 0 0 0 0 0
Totale 74.701